0001209191-21-064933.txt : 20211116 0001209191-21-064933.hdr.sgml : 20211116 20211116210346 ACCESSION NUMBER: 0001209191-21-064933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211114 FILED AS OF DATE: 20211116 DATE AS OF CHANGE: 20211116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McKenna Mark C. CENTRAL INDEX KEY: 0001749623 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40187 FILM NUMBER: 211418175 MAIL ADDRESS: STREET 1: 400 SOMERSET CORPORATE BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Prometheus Biosciences, Inc. CENTRAL INDEX KEY: 0001718852 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 814282653 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9410 CARROLL PARK DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 200-7888 MAIL ADDRESS: STREET 1: 9410 CARROLL PARK DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Precision IBD, Inc. DATE OF NAME CHANGE: 20171004 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-11-14 0 0001718852 Prometheus Biosciences, Inc. RXDX 0001749623 McKenna Mark C. C/O PROMETHEUS BIOSCIENCES, INC. 9410 CARROLL PARK DRIVE SAN DIEGO CA 92121 1 1 0 0 Chairman, President & CEO Stock Option (Right to Buy) 36.32 2021-11-14 4 A 0 290000 0.00 A 2031-11-13 Common Stock 290000 290000 D 25% of the shares subject to the option will vest on November 14, 2022, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's continued service with the Issuer through each vest date. /s/ Timothy K. Andrews, attorney-in-fact for Mark C. McKenna 2021-11-16